Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Konradi Molecular
Burlingame, CA, USA
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
Konradi Molecular is a medicinal chemistry consultancy led by Dr. Andrei W. Konradi, who has extensive experience in drug discovery with multiple candidates advanced to human trials through his career at various organizations. There is no public data indicating that the company itself has clinical results or an internal pipeline.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Konradi Molecular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Konradi Molecular.